Discover how moderate-to-vigorous physical activity can reduce exacerbations and corticosteroid use in COPD patients on dual ...

In recent years, 'long-acting' bronchodilators have been introduced. Long-acting bronchodilators have an extended period of action that reduces the need for multiple dosing, and are also more ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these ...

If an inhaled steroid does not help or does not relieve your symptoms enough, current guidelines from the National Heart, Lung, and Blood Institute recommend adding a long-acting bronchodilator ...

the development of effective and well-tolerated bronchodilators has long been an important goal in COPD therapy. Even in people with mild COPD, symptoms such as breathlessness are often apparent ...

Onbrez is a long acting bronchodilator. Each dose of Onbrez will keep your air passages open and relieve chest tightness and wheezing for 24 hours. Onbrez capsules for inhalation contain the ...